Insider Transactions

PROCTER & GAMBLE Co (PG) Insider Transactions

Over the last 12 months, 28 PROCTER & GAMBLE Co (PG) insiders filed 222 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $81.1M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 222 (1-year window)

Each row is a single Form 4 filing event for PG, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-06-09 Portman Robert Jones Grant A $0 51 $0.00
2026-06-09 McEvoy Ashley Grant A $0 202 $0.00
2026-06-09 McCarthy Christine M Grant A $0 253 $0.00
2026-06-09 Kempczinski Christopher J Grant A $0 258 $0.00
2026-06-09 JIMENEZ JOSEPH Grant A $0 320 $0.00
2026-06-09 ARNOLD CRAIG Grant A $0 202 $0.00
2026-03-10 Portman Robert Jones Grant $0 193 $0.00
2026-03-10 McEvoy Ashley Grant $0 161 $0.00
2026-03-10 McCarthy Christine M Grant $0 209 $0.00
2026-03-10 Kempczinski Christopher J Grant $0 201 $0.00
2026-03-10 JIMENEZ JOSEPH Grant $0 273 $0.00
2026-03-10 ARNOLD CRAIG Grant $0 161 $0.00
2026-02-27 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Sell $867.6K 5,249 $165.29
2026-02-27 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Sell $21.5K 130 $165.30
2026-02-27 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Sell $19.8K 120 $165.31
2026-02-27 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Sell $8.3K 50 $165.32
2026-02-19 Whaley Susan Street Chief Legal Officer & Secy Sell $288.5K 1,809 $159.46
2026-02-17 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Grant $0 57 $0.00
2026-02-17 Whaley Susan Street Chief Legal Officer & Secy Grant $0 11 $0.00
2026-02-13 Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer Grant $1.4M 15,169 $91.07
2026-02-13 Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer Grant $0 15,169 $0.00
2026-02-13 Aguilar Moses Victor Javier Chf Rsch, Dev & Innov Officer Sell $2.5M 15,169 $162.28
2026-02-12 Moeller Jon R Exec. Chairman of the Board Grant $18.4M 162,232 $113.23
2026-02-12 Moeller Jon R Exec. Chairman of the Board Grant $0 162,232 $0.00
2026-02-12 Coombe Gary A CEO - Grooming Grant $2.8M 36,093 $78.52
2026-02-12 Coombe Gary A CEO - Grooming Grant $0 36,093 $0.00
2026-02-12 Moeller Jon R Exec. Chairman of the Board Sell $26.4M 162,232 $162.45
2026-02-12 Coombe Gary A CEO - Grooming Sell $5.9M 36,093 $162.33
2026-02-11 Purushothaman Balaji Chief Human Resources Officer Grant $1.2M 12,827 $91.07
2026-02-11 Purushothaman Balaji Chief Human Resources Officer Grant $0 12,827 $0.00
2026-02-11 Moeller Jon R Exec. Chairman of the Board Grant $1.2M 11,036 $113.23
2026-02-11 Moeller Jon R Exec. Chairman of the Board Grant $0 11,036 $0.00
2026-02-11 Purushothaman Balaji Chief Human Resources Officer Sell $2.1M 12,827 $160.31
2026-02-11 Moeller Jon R Exec. Chairman of the Board Sell $1.8M 11,036 $160.00
2026-02-04 Francisco Ma. Fatima CEO - Baby, Fem & Family Care Sell $1.3M 8,000 $158.00
2026-01-23 Pritchard Marc S. Chief Brand Officer Grant $7.7M 95,903 $80.29
2026-01-23 Pritchard Marc S. Chief Brand Officer Grant $0 95,903 $0.00
2026-01-23 Pritchard Marc S. Chief Brand Officer Sell $14.5M 95,903 $151.15
2025-12-09 Portman Robert Jones Grant $0 54 $0.00
2025-12-09 McEvoy Ashley Grant $0 215 $0.00
2025-12-09 McCarthy Christine M Grant $0 269 $0.00
2025-12-09 Kempczinski Christopher J Grant $0 260 $0.00
2025-12-09 JIMENEZ JOSEPH Grant $0 341 $0.00
2025-12-09 ARNOLD CRAIG Grant $0 215 $0.00
2025-12-03 Moeller Jon R Chairman, President and CEO Grant $103.8K 719 $144.35
2025-12-03 Moeller Jon R Chairman, President and CEO Grant $23.0K 159 $144.35
2025-12-03 Moeller Jon R Chairman, President and CEO Grant $23.0K 159 $144.35
2025-12-03 Moeller Jon R Chairman, President and CEO Grant $21.8K 151 $144.35
2025-12-03 Moeller Jon R Chairman, President and CEO Grant $0 159 $0.00
2025-12-03 Whaley Susan Street Chief Legal Officer & Secy Grant $7.9K 54 $144.35

Showing the most recent 50 of 222 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track PG Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for PROCTER & GAMBLE Co?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of PROCTER & GAMBLE Co (PG) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of PROCTER & GAMBLE Co (PG) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.